These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17917464)

  • 1. Bladder training versus combination of propiverine with bladder training for female urinary frequency. A prospective, randomized, comparative study.
    Kim SW; Song SH; Ku JH
    Gynecol Obstet Invest; 2008; 65(2):123-7. PubMed ID: 17917464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
    Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
    Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial.
    Marschall-Kehrel D; Feustel C; Persson de Geeter C; Stehr M; Radmayr C; Sillén U; Strugala G
    Eur Urol; 2009 Mar; 55(3):729-36. PubMed ID: 18502028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
    Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
    Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
    Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
    Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
    Peters KM; Macdiarmid SA; Wooldridge LS; Leong FC; Shobeiri SA; Rovner ES; Siegel SW; Tate SB; Jarnagin BK; Rosenblatt PL; Feagins BA
    J Urol; 2009 Sep; 182(3):1055-61. PubMed ID: 19616802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of propiverine on improvement of symptoms and QOL for female patients with wet overactive bladder].
    Kato M; Matsukawa Y; Kato K; Kondo A; Yamada S; Hattori R; Gotoh M
    Hinyokika Kiyo; 2008 Mar; 54(3):165-71. PubMed ID: 18411770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of transcutaneous electrical nerve stimulation in children with overactive bladder refractory to pharmacotherapy.
    Malm-Buatsi E; Nepple KG; Boyt MA; Austin JC; Cooper CS
    Urology; 2007 Nov; 70(5):980-3. PubMed ID: 17919697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    Chapple C; Herschorn S; Abrams P; Sun F; Brodsky M; Guan Z
    Eur Urol; 2009 Sep; 56(3):534-41. PubMed ID: 19070418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to manage overactive bladder in elderly individuals with dementia? A combined use of donepezil, a central acetylcholinesterase inhibitor, and propiverine, a peripheral muscarine receptor antagonist.
    Sakakibara R; Ogata T; Uchiyama T; Kishi M; Ogawa E; Isaka S; Yuasa J; Yamamoto T; Ito T; Yamanishi T; Awa Y; Yamaguchi C; Takahashi O
    J Am Geriatr Soc; 2009 Aug; 57(8):1515-7. PubMed ID: 19682155
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy, tolerability and safety of propiverine hydrochloride in children and adolescents with congenital or traumatic neurogenic detrusor overactivity--a retrospective study.
    Grigoleit U; Mürtz G; Laschke S; Schuldt M; Goepel M; Kramer G; Stöhrer M
    Eur Urol; 2006 Jun; 49(6):1114-20; discussion 1120-1. PubMed ID: 16542772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of overactive bladder with sodium chondroitin sulphate].
    Gauruder-Burmester A; Wildt B; Tunn R
    Zentralbl Gynakol; 2006 Dec; 128(6):336-40. PubMed ID: 17213972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergics [corrected] in patients with overactive bladder: Assessment of ambulatory urodynamics and patient perception.
    Oh SJ; Son H; Jeong JY; Ku JH
    Neurourol Urodyn; 2007; 26(6):789-93. PubMed ID: 17594723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between oxybutynin, functional electrical stimulation and pelvic floor training for treatment of detrusor overactivity in women: a review.
    Arruda RM; Castro R; Sartori M; Girão MJ
    Curr Opin Obstet Gynecol; 2009 Oct; 21(5):412-4. PubMed ID: 19593131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticholinergic drugs versus non-drug treatment of overactive bladder syndrome in adults. A survey of a Cochrane review].
    Nordling J
    Ugeskr Laeger; 2007 Dec; 169(50):4345-7. PubMed ID: 18211791
    [No Abstract]   [Full Text] [Related]  

  • 18. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
    Bach P; Wormland RT; Möhring C; Goepel M
    Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
    Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
    Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial comment on: Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial.
    Novara G
    Eur Urol; 2009 Mar; 55(3):737. PubMed ID: 18502023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.